LabCorp Extends Tender Offer for All Outstanding Shares of Orchid Cellmark

Laboratory Corporation of America® Holdings LH today announced that LabCorp is extending until 5:00 p.m., New York City time, on November 4, 2011 LabCorp's previously announced cash tender offer for all outstanding shares of the common stock of Orchid Cellmark Inc. ORCH. On May 17, 2011, LabCorp received a request from the Federal Trade Commission, or the FTC, for additional information under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, applicable to the acquisition of Orchid by LabCorp. LabCorp previously extended its tender offer to October 7, 2011. LabCorp is continuing to cooperate with the FTC's request for additional information and is consequently further extending the expiration of the tender offer.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsOfferingsHealth CareHealth Care Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!